HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth Advocates Calcium/Colon Polyps Health Claims

This article was originally published in The Tan Sheet

Executive Summary

Wyeth Consumer Healthcare is one of several companies expressing an interest in health claims linking calcium to various disease states

Wyeth Consumer Healthcare is one of several companies expressing an interest in health claims linking calcium to various disease states.

In response to a qualified health claim petition asserting a relationship between calcium and various types of cancer, Wyeth advocates the claims "Calcium may reduce the risk of recurrent colon polyps" or "Calcium may reduce the risk of recurrent colon polyps, a major risk factor for colon cancer."

"Since adenomas are so common in the U.S. population, recommending calcium provides the public with a simple, safe and inexpensive method to help reduce their risk of developing recurrent polyps," the firm maintains.

Wyeth markets the Caltrate line of calcium carbonate supplements to support colon health and strong bones.

In support of the claims, Wyeth submitted "a review of the current guideline on colorectal polyps from the Digestive Diseases Societies...and expert opinions and assessments from four eminent scientists in the field of colon cancer prevention."

In separate comments, Howard Heller, MD, University of Texas Southwestern Medical Center, Dallas, opposes any health claim linking calcium to kidney/urinary stones because data are inconclusive.

Heller is "concerned that treatment of active kidney stone formers with calcium may exacerbate stone disease rather than ameliorate risk," he says in mid-May comments. Of importance is the fact that "the vast majority of kidney stones contain calcium."

While data showing dietary calcium in the form of dairy products may prevent kidney stones "is still controversial, [information] concerning calcium supplements is even less convincing."

There are no clinical trials comparing high doses of calcium to low doses, and it is reasonable to believe that higher calcium may cause unintended harm, he adds.

Heller's comments echo similar statements made by another UT Southwestern Medical Center researcher who argued that support for Marine Bio USA's petition tying calcium to various cancers and kidney stones was insufficient (1 (Also see "Calcium/Kidney Stones Qualified Health Claim Unsupported – Researcher" - Pink Sheet, 10 May, 2004.), p. 18).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS127947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel